(Q33574107)

28 July 2017

0 references

Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials (English)

1 reference

serotonin–norepinephrine reuptake inhibitor

28 July 2017

main subject

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

M Machado

1

1 reference

28 July 2017

T R Einarson

series ordinal

2

1 reference

28 July 2017

language of work or name

1 reference

1 April 2010

1 reference

Journal of Clinical Pharmacy and Therapeutics

28 July 2017

published in

1 reference

28 July 2017

volume

35

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

177-188

1 reference

Remission in major depression with two antidepressant mechanisms: results from a naturalistic study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Dual monoamine modulation for improved treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Challenges in systematic reviews that evaluate drug efficacy or effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Intention-to-treat analysis and the goals of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Evidence based review of escitalopram in treating major depressive disorder in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

Milnacipran. A review of its use in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2009.01050.X

10.1111/J.1365-2710.2009.01050.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference